bicycle peptide therapeutic for cancer / Bicycle Therap, Roche - LARVOL DELTA

Bicycle Therapeutics Announces Expansion of Genentech Immuno-Oncology Collaboration (Businesswire) - "Bicycle Therapeutics plc...announced that Genentech, a member of the Roche Group, has exercised an option to initiate a new program, expanding the exclusive strategic collaboration agreement with Bicycle to discover, develop and commercialize novel Bicycle®-based immuno-oncology therapies...Pursuant to the terms of the February 2020 agreement, Genentech has exercised an option to include a new program under the agreement, triggering a $10 million payment to Bicycle."

Licensing / partnership • Oncology